PLK1 and melanoma: Importantly, we observed that shRNA-mediated PLK1 knockdown in A375, WM115, and SK-MEL-2 cells (human melanoma cell lines that possess high metastatic potential) inhibited cell migration and invasion, as well as modulated the expression of EMT-related proteins.